Targeted next-generation sequencing as a diagnostic tool in gastrointestinal system cancer/polyposis patients.

The accumulation of analyses with multigene testing will increase the available data for cancer predisposition genes in hereditary gastrointestinal cancer/polyposis. Educational campaigns for prevention, efficient screening programs, and more personalized care based on the profile of individual patients are necessary.